Interventional cardiologist
West Middlesex Hospital
Joined May 2011
- Tweets455
- Following279
- Followers348
- Likes172
Henry Seligman retweeted
Amazing to see a brilliant friend and colleague @MikeFoley89 present the #ORBITA-COSMIC trial of the coronary sinus reducer with simultaneous publication in @TheLancet @rallamee @ImperialNHLI @ImperialNHS #ACC2024
thelancet.com/journals/lance…
Henry Seligman retweeted
Proud to have our TELE-ACS study presented today as a Late Breaking Trial @#ACC2024 by our fantastic fellow @alnah_ . Simultaneously published in @JACCJournals . Great team effort. @ImperialNHLI @TheBHF @ImperialNHS @DrAdamHartley @ProfDFrancis @DrJHoward
TELE-ACS: A robust telemedicine intervention across six months following an #cvACS was associated w/ a reduction in hospital readmission, emergency department visits, unplanned coronary revascularization & patient-reported symptoms. Read more: bit.ly/49sV90U
#ACC24
Henry Seligman retweeted
🆕 Comprehensive overview of TR in pts w #HeartFailure. 🫀💡#TricuspidRegurgitation
➡️ doi.org/10.1016/j.jscai.2023…
#JSCAI #HF special issue highlight 📚
@henselig @anvoramd @EeLingHeng1 @azeemlatib @RajMakkarMD
Henry Seligman retweeted
I am so proud of these tremendous people with whom I have been blessed, but especially @rallamee.
Henry Seligman retweeted
Check out our @CircIntv editorial on important work by Warisawa, Davies, et al. in @CircIntv on deferral of hemodynamically sig, intermediate LM disease.
Bottom line—go with the flow (and revascularize)!
@DrRCChester @SVRaoMD @wfearonmd @MortonKern
ahajournals.org/doi/10.1161/…
Advanced version of the paper available @ESCjournals DH today @RicardoPetraco #AI #coronaryflow #CFR #combomap
Development of #ArtificialIntelligence tools for invasive Doppler-based coronary microvascular assessment bit.ly/3nPMR1n
#EHJDigital @BruiningNico @rafavidalperez @GerdHindricks @ProfDFrancis
Great to see this study ready for publication. We used AI image processing techniques to solve decades-old problems in invasive coronary Doppler. Thanks to my supervisors @ImperialNHLI @RicardoPetraco and @ProfDFrancis.
Can AI help us on the diagnosis of coronary microvascular disease?
Outstanding innovative work by @henselig @mshunshin and the team @ImperialNHLI @ImperialNHS now accepted in @ESC_Journals digital health.
We set to use AI to improve reliability of invasive Doppler-based CFR.
Thanks also to the Unity Collaborative @mshunshin and @DrJHoward, students Sapna Patel and Anissa Aloula and the many coronary experts @JEscaned @NielsRoyen @SukhNijjer @rallamee @DrShaiSen @rajkumar_chris @MikeFoley89 @AlexNowbar @DrHaseebRahman1 @CCook_MD @YousifAhmad
Henry Seligman retweeted
Study by Akintoye et al. Right ventricle free wall strain (RVFWS) + tricuspid regurgitant volume (RVol) were strongest predictors of mortality in asymptomatic TR. The optimal discriminatory thresholds for these parameters were RVFWS <−19% and RVol >45 mL.
jacc.org/doi/abs/10.1016/j.j…
Henry Seligman retweeted
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Acute Cardiac Care and Ischaemic Heart Disease academic.oup.com/eurheartj/a…
@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #cvacute #ischaemic #heartdisease
A great few days of learning and connecting with a good crew of cardiologists in front of the camera and (crucially) in person. #PCRLV 2022. @DrHeathAdams1 @CCook_MD @dr_chrisallen @CurioJonathan @Sticchi_Alex @CaraCanDo @kiadeb87 @PCRonline
Henry Seligman retweeted
Join me @BritishCardioSo 2022 meeting in Zone 1 Education Hall at 11.15 for the interventional Hot Topic update 'Intravascular imaging update: what's new and what's in the pipeline' @TheBHF @ImperialNHLI #BCS2022 #BCS100
Henry Seligman retweeted
Aquí un nuevo 🧵para el @clinicasac sobre un tema muy actual 👉reserva coronaria de flujo y eventos cv. Imperdible meta análisis de @RicardoPetraco y equipo. Paper editor's choice @ehj_ed
📌Coronary flow reserve and cardiovascular outcomes: a systematic review & metaanalysis
doi.org/10.1093/eurheartj/eh…🆓
Autor tw @drccaroli
59 estudios c/ 59740 🧑🤝🧑
Reserva coronaria flujo (RCF) anormal, ⬆️mortalidad RR 3.7 (16 estudios/ 8446 ptes) y MACE RR 3.4 (60 estudios/ 35498 🧑🤝🧑
Henry Seligman retweeted
In our CPET-stratified analysis🏃of ORBITA published in #EHJ, we show that the presence of an oxygen pulse plateau correlated with ⬆️ ischaemia on stress echo and FFR.
Many trainees approached me at the Boston @AATSHQ meeting and asked for advice about what is the best way to hit the ground running once they graduate. I told them that they should learn how to do a CABG. That is the one procedure that you will be judged on more than any other.
An excellent piece on our recent work in European Heart Journal by @VTaqMD. How do we harness coronary flow's potential to guide us as clinicians and innovators?
@RicardoPetraco @Mihir_Kelshiker @DrJHoward
podcasts.apple.com/gb/podcas…
Henry Seligman retweeted
Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis
@escardio @ESC_Journals #CardioTwitter #EHJ
academic.oup.com/eurheartj/a…
Our work on the long-term significance of coronary flow reserve published today in EHJ @ESC_Journals. Nearly 80 studies and 60k patients. A clear link between impaired CFR and worse clinical outcomes. A superhuman effort by @Mihir_Kelshiker.
Delighted that our paper “Coronary Flow Reserve and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis” was published in EHJ @ESC_Journals ; in which we measured the prognostic association of CFR on both mortality and MACE, across all studied pathologies —
An interesting Anomalous Coronary Artery Study case. We believe so-called ‘malignant’ coronary arteries are a benign condition, in many cases, but can’t be sure. Decisions about when to offer surgery are guided by limited data. @ImperialNHLI @ImperialNHS
Not just another angiogram. A typical challenging case from our Invasive Anomalous Coronary Artery Study @ImperialNHLI led by @henselig
Do these malignant arteries really cause ischaemia? We are seeking to answer it invasively as well as with echo and MRI.